Abstract | PURPOSE: METHODS: In this open-label study, patients aged 1-30 years entered a 4-week baseline phase, followed by a 4-week stiripentol dose-adjustment and 12-week fixed-dose phase. The primary efficacy endpoint was responder rate (proportion of patients with a ≥50% reduction from baseline phase in clonic or tonic-clonic seizure frequency over the last 4 weeks of fixed-dose treatment [target phase]). Safety and pharmacokinetics were also assessed. KEY FINDINGS: Of 27 patients screened in the baseline phase, 24 patients entered the dose-adjustment phase. All patients completed the study. Responder rate was 66.7% (16/24, 95% CI: 44.7-84.4%), and four patients became free from clonic or tonic-clonic seizures. The duration of clonic or tonic-clonic seizures was also significantly reduced in the target versus baseline phase. The most frequent adverse events were somnolence, anorexia, ataxia, nasopharyngitis and γ- glutamyl transpeptidase increase, all of which were of mild-to-moderate severity. Stiripentol plasma concentration in the fixed-dose phase was 4-25 μg/mL. After adding stiripentol to CLB and VPA, the minimum plasma concentrations of CLB and N-desmethyl-CLB (NCLB) increased and that of 4'-hydroxy-N-desmethyl-CLB(OH-NCLB) decreased, while those of VPA and bromide (optionally used) were not affected. SIGNIFICANCE:
|
Authors | Yushi Inoue, Yoko Ohtsuka, STP-1 Study Group |
Journal | Epilepsy research
(Epilepsy Res)
Vol. 108
Issue 4
Pg. 725-31
(May 2014)
ISSN: 1872-6844 [Electronic] Netherlands |
PMID | 24630050
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier B.V. All rights reserved. |
Chemical References |
- Anticonvulsants
- Dioxolanes
- Benzodiazepines
- Clobazam
- Valproic Acid
- stiripentol
|
Topics |
- Adolescent
- Adult
- Anticonvulsants
(administration & dosage, adverse effects, therapeutic use)
- Asian People
- Benzodiazepines
(administration & dosage, adverse effects, therapeutic use)
- Child
- Child, Preschool
- Clobazam
- Dioxolanes
(administration & dosage, adverse effects, therapeutic use)
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Therapy, Combination
- Epilepsies, Myoclonic
(drug therapy)
- Female
- Humans
- Infant
- Japan
- Male
- Treatment Outcome
- Valproic Acid
(administration & dosage, adverse effects, therapeutic use)
- Young Adult
|